Neueste Versuche


EudraCT Number: 2017-004851-22 Sponsor Protocol Number: B7451015 Start Date:
Sponsor Name: Pfizer Inc., 66 Hudson Boulevard East, New York, NY 10001, U.S.A.
Full Title: A phase 3 multi-center, long-term extension study investigating the efficacy and safety of Abrocitinib, with or without topical medications, administered to subjects aged 12 years and older with m...
Medical condition: Moderate to severe atopic dermatitis
Disease: Version SOC Term Classification Code Term Level
21.1 100000004858 10003639 Atopic dermatitis LLT
Population Age: Adolescents, Under 18, Adults, Elderly Gender: Male, Female
Trial protocol: DE (Ongoing) GB (GB - no longer in EU/EEA) CZ (Ongoing) HU (Trial now transitioned) PL (Ongoing) NL (Ongoing) BG (Ongoing) BE (Ongoing) LV (Ongoing) ES (Ongoing) SK (Completed) FR (Completed) AT (Completed) SE (Prematurely Ended) IT (Ongoing) FI (Ongoing) RO (Ongoing)
Trial results: (No results available)

EudraCT Number: 2018-004828-11 Sponsor Protocol Number: RECHMPL18_0038_prom_7574 Start Date:
Sponsor Name: University Hospital of Montpellier
Full Title: Phosphodiesterase-type 5 inhibitors in adult and adolescent patients with univentricular heart disease: a multi-center, randomized, double blind phase III study
Medical condition: adult and adolescent patients with univentricular heart diseases and pulmonary arterial pressure
Disease: Version SOC Term Classification Code Term Level
Population Age: Adolescents, Under 18, Adults Gender: Male, Female
Trial protocol: FR (Ongoing)
Trial results: (No results available)
EudraCT Number: 2017-003220-78 Sponsor Protocol Number: I8B-MC-ITSA Start Date:
Sponsor Name: Eli Lilly and Company
Full Title: A Study to Evaluate the Pharmacokinetics and Glucodynamics of LY900014 Compared to Humalog in Children, Adolescents, and Adults with Type 1 Diabetes Mellitus
Medical condition: Diabetes Mellitus, Type 1
Disease: Version SOC Term Classification Code Term Level
20.0 10027433 - Metabolism and nutrition disorders 10012601 Diabetes mellitus PT
Population Age: Children, Adolescents, Under 18, Adults Gender: Male, Female
Trial protocol: DE (Completed)
Trial results: View results

EudraCT Number: 2014-002442-45 Sponsor Protocol Number: AXAFA-AFNET5 Start Date:
Sponsor Name: Kompetenznetz Vorhofflimmern e.V. [Atrial Fibrillation NETwork (AFNET)]
Full Title: Anticoagulation using the direct factor Xa inhibitor apixaban during Atrial Fibrillation catheter Ablation: Comparison to vitamin K antagonist therapy.
Medical condition: Atrial fibrillation catheter ablation
Disease: Version SOC Term Classification Code Term Level
19.0 10007541 - Cardiac disorders 10003658 Atrial fibrillation PT
19.0 10007541 - Cardiac disorders 10071667 Persistent atrial fibrillation LLT
19.0 10007541 - Cardiac disorders 10003661 Atrial fibrillation paroxysmal LLT
19.0 10007541 - Cardiac disorders 10066582 Recurrent atrial fibrillation LLT
Population Age: Adults, Elderly Gender: Male, Female
Trial protocol: DE (Completed) BE (Completed) DK (Completed) GB (Completed) NL (Completed) ES (Completed) AT (Completed)
Trial results: (No results available)
EudraCT Number: 2006-006907-35 Sponsor Protocol Number: SP915 Start Date:
Sponsor Name: Schwarz Biosciences GmbH
Full Title: Long-term extension of RECOVER A MULTICENTER, MULTINATIONAL, PHASE 3B, OPEN-LABEL EXTENSION TRIAL TO EVALUATE THE LONG-TERM EFFECT OF THE 24-HOUR TRANSDERMAL DELIVERY OF ROTIGOTINE ON MOTOR FUNCTI...
Medical condition: Parkinson's disease
Disease: Version SOC Term Classification Code Term Level
9.1 10061536 Parkinson's disease LLT
Population Age: Adults, Elderly Gender: Male, Female
Trial protocol: DE (Prematurely Ended) FI (Completed) ES (Completed) HU (Completed) IT (Completed) GB (Completed) AT (Prematurely Ended)
Trial results: View results

EudraCT Number: 2005-005641-19 Sponsor Protocol Number: ENG K001 GF / EC 406 Start Date:
Sponsor Name: Takeda Pharma GmbH
Full Title: 3 Months, Open-Label, Parallel-Group Study of the Pharmacodynamics, Pharmacokinetics and Safety of TAP-144SR 1-month Depot Gelatin-Free vs. Gelatin-Containing Formulation in Female Patients with Ut...
Medical condition: Uterine fibroids (Uterus myomatosus)
Disease: Version SOC Term Classification Code Term Level
8.0 10046784 LLT
Population Age: Adults Gender: Female
Trial protocol: DE (Completed)
Trial results: View results
EudraCT Number: 2019-003676-39 Sponsor Protocol Number: 109147 Start Date:
Sponsor Name:
Full Title: Effects of sodium lactate infusion in patients with glucose transporter 1 deficiency syndrome (GLUT1DS)
Medical condition: In glucose transporter 1 deficiency syndrome (GLUT1DS) cerebral glucose uptake from the systemic blood circulation is limited, because of deficient transport of glucose across the blood-brain barri...
Disease: Version SOC Term Classification Code Term Level
Population Age: Children, Under 18 Gender: Male, Female
Trial protocol: NL (Ongoing)
Trial results: (No results available)

EudraCT Number: 2006-006912-31 Sponsor Protocol Number: AMV-12_12_2006 Start Date:
Sponsor Name: Universitätsklinikum Schleswig-Holstein
Full Title: Vereidung maschineller Beatmung bei sehr kleinen Frühgeborenen - Avoid mechanical ventilation (The AMV-Trial)
Medical condition: Respiratory distress syndrom of preterm infants (ICD 10: P22.0)
Disease: Version SOC Term Classification Code Term Level
Population Age: Preterm newborn infants, Under 18 Gender: Male, Female
Trial protocol: DE (Ongoing)
Trial results: (No results available)
EudraCT Number: 2020-000412-30 Sponsor Protocol Number: LF111/401 Start Date:
Sponsor Name: Chemo Research S.L.
Full Title: A multicenter, open-label, controlled study to investigate the effect of either LF111 or Drospirenone chewable tablets on bone mineral density (BMD) in adolescent and adult women in comparison with...
Medical condition: Oral contraception
Disease: Version SOC Term Classification Code Term Level
21.0 10022891 - Investigations 10049470 Bone density decreased PT
Population Age: Adolescents, Under 18, Adults Gender: Female
Trial protocol: CZ (Ongoing) PL (Ongoing)
Trial results: (No results available)

EudraCT Number: 2019-000205-77 Sponsor Protocol Number: KF5503-75 Start Date:
Sponsor Name: Grünenthal GmbH
Full Title: Open-label investigation of the pharmacokinetic profile, safety, tolerability, and efficacy of multiple administrations of tapentadol oral solution used for treatment of acute pain in children aged...
Medical condition: Moderate to severe acute pain
Disease: Version SOC Term Classification Code Term Level
20.1 100000004867 10066714 Acute pain LLT
Population Age: Children, Under 18 Gender: Male, Female
Trial protocol: PL (Completed)
Trial results: View results
3
Abonnieren